Literature DB >> 11601749

Induced sputum in the diagnosis of peripheral lung cancer not visible endoscopically.

C Agustí1, A Xaubet, C Montón, M Solé, N Soler, M Carrión, R Rodriguez Roisín.   

Abstract

The diagnosis of small peripheral lung cancer is difficult to achieve by non-invasive methods. We hypothesized that in these patients induced sputum might ncrease the diagnostic yield over spontaneous sputum, representing a good diagnostic alternative in selected patients. We prospectively evaluated 60 patients with peripheral lung lesions and normal bronchoscopic evaluation. Six samples of sputum (three spontaneous and three induced with nebulization of hypertonic saline) before bronchoscopy and six samples of sputum after bronchoscopy (three spontaneous and three induced) were obtained in each subject. Forty-two out of the 60 patients included were finally diagnosed with lung cancer. Eighteen patients were diagnosed with different benign conditions of the lung. Overall, malignant cells in sputum were observed in 21 patients and in all but one, the final diagnosis of lung cancer was achieved. Only one patient with a pseudoinflammatory tumour of the lung had a false-positive result in one spontaneous sputum sample. The diagnosis of lung cancer was obtained in 18 patients with the induced sputum (43%) and in 14 patients with spontaneous sputum (31%) (P=NS). Samples of induced sputum were more adequate for cytological analysis than samples of spontaneous sputum (P < 0.001). Of 13 patients with peripheral lung neoplasms of 2 cm or less in diameter, five were diagnosed using induced sputum (38%) and only one using spontaneous sputum (8%) (P<0.05). In conclusion, induced sputum is a valuable technique for the diagnosis of peripheral lung cancer. Induced sputum gives better quality specimens and better diagnostic yield in small lesions than the spontaneous sputum and may be indicated in selected patients with disseminated disease, inoperability or severe co-morbities.

Entities:  

Mesh:

Year:  2001        PMID: 11601749     DOI: 10.1053/rmed.2001.1173

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  Sputum examination for early detection of lung cancer.

Authors:  F B J M Thunnissen
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Sputum cytology for lung cancer: Not just part of the past.

Authors:  Naveen Dutt; Anup Kumar Singh
Journal:  Lung India       Date:  2012-04

3.  Metastatic ampullary adenocarcinoma in exfoliative sputum cytology: A rare presentation.

Authors:  Maitrayee Roy; Shipra Agarwal; Asit Ranjan Mridha; Jyoti Arora; Karan Madan; Deepali Jain; Sandeep Mathur
Journal:  Lung India       Date:  2015 Sep-Oct

4.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.

Authors:  Evgeny Izumchenko; Xiaofei Chang; Mariana Brait; Elana Fertig; Luciane T Kagohara; Atul Bedi; Luigi Marchionni; Nishant Agrawal; Rajani Ravi; Sian Jones; Mohammad O Hoque; William H Westra; David Sidransky
Journal:  Nat Commun       Date:  2015-09-16       Impact factor: 14.919

Review 5.  DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer.

Authors:  Catherine Leygo; Marissa Williams; Hong Chuan Jin; Michael W Y Chan; Wai Kit Chu; Michael Grusch; Yuen Yee Cheng
Journal:  Dis Markers       Date:  2017-09-05       Impact factor: 3.434

6.  Sputum analysis by flow cytometry; an effective platform to analyze the lung environment.

Authors:  Lydia H Bederka; Jamila R Sanchez; Jennifer Rebeles; Patricia R Araujo; Marcia H Grayson; Shao-Chiang Lai; Louis R DePalo; Sheila A Habib; David G Hill; Kathleen Lopez; Lara Patriquin; Robert Sussman; James Humphreys; Xavier T Reveles; Vivienne I Rebel
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

7.  Transbronchial catheter aspiration compared to forceps biopsy in the diagnosis of peripheral lung cancer.

Authors:  Karl-Josef Franke; G Nilius; K-H Ruhle
Journal:  Eur J Med Res       Date:  2009-01-28       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.